Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 5 years ago

Possible Interaction: Deferoxamine and Ferric Ion

supplement:

Ferric Ion

Research Papers that Mention the Interaction

“Importantly, when the DFO was preloaded together with Fe3+ [Fe(III)-DFO], the radiosensitizing effect was lost.”
Radiation research  •  2001  |  View Paper
“ Deferoxamine is a potent chelator of ferric iron.”
“The inhibitory effects are reversible and are overcome when ferric iron is present along with deferoxamine in a 2:1 molar ratio.”
Shock  •  1996  |  View Paper
“Intracellular iron quantification indicated that, as deferoxamine , exogenous NO significantly decreased intracellular ferric iron levels in tumor cells.”
Cancer research  •  2001  |  View Paper
“This study demonstrates that DFO is a potent S-phase inhibitor of DNA synthesis in human lymphocytes in vitro, and this inhibitory effect of DFO is reversible by adding appropriate amounts of ferric ion.”
Chinese medical journal  •  1989  |  View Paper
“Addition of the iron chelator desferrioxamine to reduce the accumulation of ferric iron from heme by HO-1 resulted in blockade of the aggravated oxygen radical production.”
Toxicological sciences : an official journal of the Society of Toxicology  •  2008  |  View Paper
“As one potential source of ROS formation we identified the lysosomal Fe(2+) pool, since the ferric ion chelator deferoxamin inhibited ROS formation by approximately 15%.”
Aquatic toxicology  •  2004  |  View Paper
“The addition of Fe(III) to the dialyzed solution of Apo-ferritin: DFO resulted in the appearance of an orange-red color.”
Journal of inorganic biochemistry  •  2004  |  View Paper
“ Desferrioxamine prevented death caused by Fe+3 , had no significant effect of the toxicity of Zn+2, and increased that caused by Cu+2.”
Brain Research  •  2001  |  View Paper
“This residual MPP+ production appeared to be iron‐dependent since it was decreased (30 to 50%) by iron chelators, i.e., deferoxamine or phenanthroline, and was enhanced (by approximately 40%) in the presence of ADP‐Fe3+. ”
Glia  •  1995  |  View Paper
“The relatively slow binding of Fe(III) by deferrioxamine also affected lipid peroxidation, an iron-dependent process.”
Archives of biochemistry and biophysics  •  1992  |  View Paper
Show More